The Prescription: 1st April 2018 Issue
Editor’s EmulsionPSM INDIA Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSM Pill DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
News Archive

Pooja Khaitan

Greetings on yet another edition of The Prescription!

Fake medicines has always been an issue of grave concern for all. The manufacturers of these life threatening pills go to any extent to contaminate the market with their illegal products, costing heavy on the lives of many. PSM India capsule captures the details on this menace.

On one hand, while the AP government plans to implement the Comprehensive Drug Monitoring System to facilitate better inventory and supply chain management by manufacturers /wholesalers/ retailers/doctors to keep a tab on the medicine being supplied in the State; Tamil Nadu government, on the other hand decides to make registration for hospitals, clinics mandatory. This will ensure basic standards and also help the state crackdown on quackery. Read more on this and other news such as drug labelling notification rule, health ministry finalising the draft bill to establish national electronic health authority, regulatory body formed for medical devices under Drug Laws and Policy Injections.


Do not hesitate to mail your comments on this edition to help us further improve. We appreciate your support and trust in us and are happy to have you as our loyal reader.
Feedback is what keeps us going. Should you have any query or question, please feel free to get in touch with us. Write to me on

The request we made in our 1st January issue of The Prescription of each one touching 5 lives this year, including yourself, with your positive actions remains to be seen. Post your pics on our facebook wall or chirp it on our twitter handle. Go ahead and reach out.

Stay Healthy. Stay Protected.

Pooja Khaitan

The Prescription


"I dream of a Digital India where quality healthcare percolates right up to the remotest regions powered by e-Healthcare"

Hon’ble Prime Minister,
Shri Narendra Modi

PSM India Capsules

Your Medicine Box May Have Fake Drugs

Bought an antacid or multivitamin lately which did not seem to have any effect? It might have been fake medicine manufactured locally by an inter-state syndicate which, apart from producing the drugs, was also printing their labels, strips and packaging them. Raids by the crime branch have led to the seizure of more than 90,000 capsules and tablets of antacids and multivitamins commonly consumed in every household. Cops are trying to find where the suspects procured the “salt” — a licensed item to produce the fake medicines.

Read More
Drug Laws & Policy Injections
Rule 96 (1) (I) (A) Of Drugs And Cosmetics Rules Is Amended Wef 13.9.2018New Delhi, 13 March 2018: MoH vide notification No. GSR 222 (E) dated 13.3.2018 has amended the Rule 96 (1) (i) (A) of labelling provision for printing the proper name of the drug in a more conspicuous manner than the trade name. As per the Gazette notification in Rule 96 (1) (i) (A), for the portion beginning with the words “For this purpose” and ending with the words “name and shall be”, the words “For this purpose, the proper name of the drug or fixed dose combination drug other than fixed dose combinations of vitamin and other fixed dose combinations containing three or more drugs, shall be printed or written in a conspicuous manner which shall be in the same font but at least two font size larger than the brand name or the trade name, if any, and in other cases the brand name or the trade name, if any, shall be written in brackets below or after the proper name and shall be” shall be substituted.Read More
Health Ministry Finalises Draft Bill To Establish National Electronic Health Authority New Delhi, 23 March 2018: The Union health ministry has finalised the draft of the proposed Digital Information Security in Healthcare Act (Disha), a crucial step in establishing the National Electronic Health Authority (NeHA), a nodal agency for creating regulatory framework and guidelines for interoperability and exchange of digital healthcare data in the country.. Read More
Govt Committed To Foster Entrepreneurial Ecosystem: PrabhuNew Delhi, 23 Mar 2018 (UNI): Commerce Minster Mr Suresh Prabhu on Friday said the government was committed to foster entrepreneurial ecosystem in the country. Participating in a roundtable meeting on regulatory issues with startups and representatives of various Ministries here the Commerce Minister said the government was concerned about the regulatory issues being faced by the startups in the country and was trying to solve them. Read More
Tamil Nadu Govt Makes Registration Of Hospitals, Clinics MandatoryCHENNAI, 23 MARCH 2018: The state assembly on Thursday passed a legislation making it mandatory for all clinical establishments in the state – public or private – to register themselves with the government. Besides giving the state statistics on healthcare facilities, it will ensure basic standards and also help the state crackdown on quackery, health minister Dr C Vijayabaskar said. Read More
AP Govt Plans To Implement CDMSVIJAYAWADA, 17 MARCH 2018: The State government is contemplating implementing the Comprehensive Drug Monitoring System (CDMS) to facilitate better inventory and supply chain management by manufacturers /wholesalers/ retailers/doctors to keep a tab on the medicine being supplied in the State. “Once it is in place, it will prevent entry of spurious drugs in the State,” said Finance Minister Yanamala Ramakrishnudu. Read More
Regulatory Body For Medical DevicesNew Delhi, 16 March 2018: The National Health Policy, 2017 recommends strengthening regulation of medical devices and establishing a regulatory body for medical devices to unleash innovation and the entrepreneurial spirit for manufacture of medical device in India. The policy supports harmonization of domestic regulatory standards with international standards. Read More
Pharma Injections
Pharma Firms Under Scanner For Selling Drugs Without Safety Trials New Delhi, 20 March 2018: Worries over combination drugs flooding the Indian market without being tested for efficacy or safety emerged again, with many domestic drug makers coming under the scanner after raids by the central drug licensing authority last week.Read More
Anti-Dumping Duty Imposed On Ofloxacin Imports From ChinaNEW DELHI, 18 MARCH 2018: India has imposed anti-dumping duty on import of Chinese pharma product, used in the treatment of certain infections, to protect domestic producers from below-cost shipments. The duty on import of ‘Ofloxacin’ from China will be in the range of $2.58 to $9.48 per kg for three years, said a notification issued by the Revenue Department in the Finance Ministry.Read More
Firm Under CDSCO Lens Over ‘Unapproved’ Drugs HYDERABAD, 22 MARCH 2018: After conducting raids on the companies allegedly manufacturing “unapproved” drugs in Haridwar in Uttarakhand, the Central Drugs Standard Control Organisation (CDSCO) has decided to issue notices to the firms, including those located in Hyderabad, for marketing them. Read More
Pharma Exports Do Not Need Regulator's Approval, Govt Tells Companies New Delhi, 22 March 2018: Pharmaceutical companies will no longer have to obtain a drug regulatory clearance for exporting drugs and medical devices, the government said on Wednesday in a step aimed at making it easier to do business. According to a notice put out on Wednesday by the Central Drugs Standard Control Organisation (CDSCO), all pharma exporters can continue exporting without having to obtain no-objection certificates (NOC) from the regulatory authorities. Read More
Doctors Of Royapettah Hospital Bring Out A Book On Toxicology Chennai, 23 March 2018: Doctors of the Department of Internal Medicine at Government Royapettah Hospital have brought out a book, Manual of Toxicology — An Indian Perspective, which, they say, will fill a lacunae in the knowledge about poisons. “Most toxicology manuals are silent on many of the Indian posions, as they have been written from a western perspective. This book is based on our experience treating cases involving toxins,” says Dr. A. Shaik Sulaiman Meeran, one of the doctors who spearheaded this book project. Read More
Drug Dopes
Updated LIST OF NEW DRUGS APPROVED FROM 01-01-2018 TILL DATE BY NEW DRUGS DIVISION, CDSCO, FDA Bhawan, New Delhi List of New Drug Approved by FDA Read More
Two Arrested With Psychotropic Drug Injections In VadodaraVADODARA, 20 MARCH 2018: The special operations group (SOG) seized a big stock of drugs from the old city area on Monday and arrested two persons. One of them is an accused in a murder case and member of the notorious Bicchu Gang. Police seized 1,000 injections of pentazocine, which is listed as a psychotropic drug, from the duo. Read More
CDSCO Raids 2 Firms In U'khand For Making Drugs Without ApprovalNew Delhi, 17 March 2018: The Central Drug Standards Control Organisation (CDSCO) has conducted raids at two firms based in Haridwar and Roorkee and is mulling cancellation of their licenses for manufacturing and selling medicines without approval from the drug regulator, officials said today. Read More
NCB Busts Illegal Pharma Drugs Trafficking Racket, Seizes Over 55000 Tablets, 4 Arrested New Delhi, 17 March 2018: Narcotics Control Bureau (NCB) has busted an illegal pharma drugs trafficking racket with the arrest of four persons and seized over 55,000 tablets of Zolpidem, abused as drugs, from their possession, the agency said today. Read More
Fake Medicine Factory Busted In Alwar Dist, Owner Arrested Jaipur, 21 March 2018: Three days after busting a gang involved in manufacturing of spurious and fake medicines and drugs, the ISC crime branch of Delhi police on Tuesday have busted a factory involved in the manufacturing of fake medicines in Bhiwadi town of Alwar district. It was a joint operation in which the factory owner Naveen Kumar Bansal (31) has also been arrested. Read More
Factory Owner Held For Manufacturing Spurious Medicines New Delhi, 17 March 2018: The Delhi Police arrested a factory owner and his associate on the charge of manufacturing spurious medicines here, police said on Saturday. Police said the accused have been identified as Ashok Kumar, 42, who runs a factory manufacturing dye cutting and pasting of medicine strips, and his associate Bijender Singh, 55. Read More
National Injections
On World TB Day, Health Ministry Launches New Initiatives To Combat TB New Delhi, 24 March 2018: "We are already aligned with world TB treatment protocols. It has to a mission to End TB by 2025, through community participation, involving civil societies and other stakeholders.” This was stated by Smt. Preeti Sudan, Secretary (Health) at a function on the occasion of ‘World TB Day’, here today. Read More
Wockhardt, Two Others Under Lens For Selling Drugs Without ApprovalNew Delhi, 16 March 2018: Major drug makers, including Wockhardt Ltd, are under the scanner of the pharma regulator for allegedly launching combination drugs to treat diabetes and fungal infection without mandatory prior approval.Read More
Drug-Resistant TB Cases In Mumbai Up 36% In 3 Years MUMBAI, 24 MARCH 2018: The menace of drug-resistant TB grew by 36% in the city in the last three years, shows latest data by the BMC’s public health department. While 3,608 multi-drug resistant (MDR) TB patients were identified in Mumbai in 2015, the number climbed to 4,891 in 2017. Read More
Counterfeit Market In India Worth Over ₹ 40,000 Cr: ASPA New Delhi, 18 March 2018: The market for fakes in India has grown steadily and stands at a whopping over ₹ 40,000 crore even as law enforcement remains weak, the Authentication Solutions Providers Association (ASPA) said on Sunday. Read More
Inform Govt About TB Patient, Earn ₹ 1,000 From April 1 BENGALURU, 22 MARCH 2018: If you know of any tuberculosis patient and tip off the district TB officer beginning April 1, you will get an incentive of ₹ 1,000, thanks to a state government initiative. Read More
Drug-Resistant TB: New Treatment Generates Hope Jaipur, 24 March 2018: New shorter multidrug-resistant tuberculosis (MDR-TB) regimen is now a silver lining for TB patients in the state. Apart from providing new regimen of treatment, health department has also laid emphasis on notifying each and every case of tuberculosis. Read More
Global Injections
US FDA Launches Mobile Version Of Drug Information Database Maryland, 23 March 2018: The FDA has launched a free mobile app version of its Drugs@FDA online database that offers consumers information on agency-approved drugs. The new app, called Drugs@FDA Express, is free and currently available for download on iOS and Android. Read More
Researchers Develop Unique Technology To Overcome Global Antibiotic Resistance Crisis England, 23 March 2018: Researchers from AGA Nanotech ltd, working with University College London (UCL), have developed a unique alternative to antibiotics. Read More

Surprising Number Of Common Medications Impact The Gut Microbiome Heidelberg, 23 March 2018: A study of more than 1,000 medications spanning all therapeutic classes showed that one in four non-antibiotic drugs inhibited the growth of at least one species of bacteria in the gut microbiome.Read More

Older Epilepsy Patients More Likely To Experience AED, Non-AED Drug Interaction Older adults with epilepsy and comorbid conditions have the highest likelihood of being prescribed a combination of nonepilepsy drugs (NEDs) and antiepileptic drug (AEDs), which could contribute to pharmacokinetic interactions and alteration in AED effectiveness, according to findings from a retrospective study published in Epilepsia.Read More

A Synthetic Microbe Could Be the Next Antibiotic Researchers working at IBM's labs have developed a new kind of synthetic molecule that targets superbugs without some of the worst side effects of conventional antibiotics.Read More

WHO Launches Health Review After Microplastics Found In 90% Of Bottled Water Genewa, 15 March 2018: The World Health Organisation (WHO) has announced a review into the potential risks of plastic in drinking water after a new analysis of some of the world’s most popular bottled water brands found that more than 90% contained tiny pieces of plastic. A previous study also found high levels of microplastics in tap water.Read More


DOJ Announces Charges Against Four In Counterfeit Drug Case In Puerto Rico

March 22, 2018: According to the U.S. Food and Drug Administration, a federal grand jury came back with a 28-count indictment against four individuals in Puerto Rico for a range of charges including trafficking in counterfeit goods, distribution of a controlled substance, and smuggling. According to the indictment, the defendants in the case, Carlos Enrique Velázquez-Gines, Mayra Evelise Gines-Otero, Noriam Ivette Flores-Deleon, and Vanessa Marrero-Hernández, marketed multiple dietary supplements through online platforms such as for male enhancement and weight loss pills. Testing showed that many of the male enhancement pills contained sildenafil, the active ingredient in Viagra and Cialis, but did not list it as an ingredient. The group is also accused of selling counterfeit condoms.

Read More

FDA Warns Influenza Sufferers To Be Wary Of Counterfeit And Unapproved Flu Treatments

March 21, 2018: At the beginning of March, the U.S. Food and Drug Administration (FDA) posted a warning to the public about “fraudulent and unapproved flu products.” FDA Commissioner Scott Gottlieb, M.D. explained that, “As the flu continues to make people sick — and even cause deaths — unscrupulous actors may also be taking advantage of unsuspecting consumers by promoting their fraudulent products that have not been reviewed by the FDA to be safe and effective. The FDA is warning consumers to be alert, and try and steer clear of fraudulent flu products, which may be found online or in retail stores. We’re advising consumers on some of the telltale signs to look for when trying to spot flu products that may be fraudulent.”

Read More

Frequently Asked Questions Part 3- All you wanted to know on Universal Health Coverage
(Part 1 and Part 2 may be found in newsletters dated 1st March and 17th March respectively, on our website

Q1: Who will deliver UHC services?
The government will invest in ensuring adequate numbers of trained healthcare providers at the different levels of care. There will thus be greater recruitment and training for the delivery of UHC services by community health workers (such as ASHAs), nurses, rural healthcare practitioners (who will be trained by the proposed 3-year Bachelor of Rural Health Care program), allopathic doctors, AYUSH workers, and allied health professionals. A trained and equipped works force will be available at both public and privately contracted in facilities.
Q2: Who will manage the system?
Ans: The government will set up new all India and state level Public Health Service Cadres and a specialized state level Health Systems Management Cadre in order to give greater attention to public health and also strengthen the management of the UHC system. The human resources will be managed by autonomous, specialized agencies for regulation, evaluation and health promotion.Read More>>>


How To Avoid Endocrine Disruptors

Article contributed by our subscriber,Dr. Prakash, USA. If you wish to share articles on healthcare, and see them published here, please mail them to our Editor-in-Chief,

Florida, 12 March 2018: Endocrine disruptors are chemicals that interfere with the endocrine — or hormone — system. More than 150 studies have linked endocrine-disrupting chemicals to a long list of health problems, including heart disease, obesity, breast and prostate cancer, diabetes, infertility, and the feminization of males. Read More

Upcoming Events
UpComing Events
Click Here For More Events
Laughter Dose
Blog Addicts
Aasha healthy live foundation remarks: We support the fight against fake medicines. We are with you.
Mr. Prakash, health care activist blogs:Very Good Initiative , Hope the citizens of India become more aware towards the cause.
Mr. Nikhil, pharmacist by profession comments: PSM India has proved “Where there is a will, there is always a way”.
This Newsletter is brought to you by
© 2011 Partnership for Safe Medicines India
F-9, 2nd floor, Kailash Colony, New Delhi -110048;;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources . PSM India may not be held responsible for any article published in The Prescription.UnSubscribe Link